Information Processing by Post-translational Modification
通过翻译后修饰进行信息处理
基本信息
- 批准号:10013233
- 负责人:
- 金额:$ 36.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-12-15 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:ADP ribosylationAcetylationAddressAffectAlzheimer&aposs DiseaseAmino AcidsBiochemicalBiological ProcessBiophysicsCell physiologyCellular biologyChemicalsCodeCollaborationsComputer softwareComputing MethodologiesDNA Double Strand BreakDataDiseaseEtiologyExhibitsExplosionFoundationsGenomeGoalsGrantHome environmentIn VitroLanguageLearningMalignant NeoplasmsMass Spectrum AnalysisMathematicsMeasuresMethodologyMethodsMethylationModificationMolecularMolecular BiologyOrganismPathway interactionsPatternPeptidesPhosphorylationPhysiologic pulsePhysiologicalPlayPopulationPost-Translational Protein ProcessingProcessProtein p53ProteinsRecombinantsRoleSiteSoftware ToolsTP53 geneTechnologyTestingTimeTumor Suppressor ProteinsUbiquitinationWorkbasechemical groupcombinatorialgamma irradiationgenetic regulatory proteinhigh dimensionalityin vivoinformation processinginsightmathematical methodsmathematical modelmultidisciplinaryprotein functionprotein structureresponsesingle molecule
项目摘要
Summary/Abstract
Most proteins in an organism are reversibly modified by covalent attachment of chemical groups to
specific amino-acid residues. Such “post-translational modification” (PTM) allows protein function to
be modulated on a physiological time-scale. PTMs are involved in regulating most cellular processes
and frequently disordered in major diseases. It is not uncommon for a protein to have many types of
modification, for these to occur on multiple sites across the protein and for modifications on different
sites to interact combinatorially to influence protein function. This can create an explosion of
combinatorial modification states. The tumor suppressor p53, on which this proposal will focus, has
more than 100 sites of modification, creating the potential for more than 1030 combinatorial
modification states on this single protein. Very few of these states will be present at any time but that
leaves open the question of which states are present and how they vary under different cellular
conditions. Our previous work has laid a foundation for addressing these questions. We have
introduced the quantitative language of “modforms” and “modform distributions”, which provide a
rigorous biophysical basis for describing PTM states in vivo. We have created mathematical methods
for analyzing the mass-spectrometry (MS) approaches which can measure such distributions and
have determined their fundamental limits. We have shown the necessity of combining “bottom-up” and
“middle-down” MS, in which proteins are first digested in peptides, with “top-down” MS on whole
proteins. These different types of MS data constrain a protein's modform distribution within a high-
dimensional “modform region”. We have developed publicly-accessible software for estimating such
regions. We have discovered that p53 integrates its pulsatile expression dynamics and its PTM state
to act as a central cellular hub and orchestrate multiple downstream pathways in response to multiple
upstream conditions. Here, we build on these findings with a tested multi-disciplinary group of
collaborators, whose expertise spans mathematics, computation, cell biology and mass spectrometry.
Our goal is to develop MS methods to estimate modform regions of typical cellular proteins and to use
those methods to unravel how p53 combines dynamics and modforms to process information. By
focusing on such a challenging exemplar, we expect to learn a great deal about p53 itself while
developing concepts and methods that can be widely applied to other cellular proteins in which PTMs
play a central role.
摘要/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEREMY GUNAWARDENA其他文献
JEREMY GUNAWARDENA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEREMY GUNAWARDENA', 18)}}的其他基金
Information Processing by Post-translational Modification
通过翻译后修饰进行信息处理
- 批准号:
10189634 - 财政年份:2014
- 资助金额:
$ 36.62万 - 项目类别:
Information Processing by Post-translational Modification
通过翻译后修饰进行信息处理
- 批准号:
9817314 - 财政年份:2014
- 资助金额:
$ 36.62万 - 项目类别:
Information Processing by Post-translational Modification
通过翻译后修饰进行信息处理
- 批准号:
8814029 - 财政年份:2014
- 资助金额:
$ 36.62万 - 项目类别:
Information Processing by Post-translational Modification
通过翻译后修饰进行信息处理
- 批准号:
10430115 - 财政年份:2014
- 资助金额:
$ 36.62万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 36.62万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 36.62万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 36.62万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 36.62万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 36.62万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 36.62万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 36.62万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 36.62万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 36.62万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 36.62万 - 项目类别: